Johnson & Johnson Facing Continued Legal Pressure Over Manufacturing Violations
Johnson & Johnson, one of the world’s largest drug and health care products manufacturers, is facing increasing pressure from the Department of Justice and the FDA over continued manufacturing violations at three of its planets.
The company’s McNeil division has been in violation of federal law and recently entered into an agreement with the Department of Justice and FDA to fix the deficiencies. The FDA has maintained these are “strong” but “necessary” steps to ensure quality and safety of the products put on the market.
The company has recalled numerous products over the past year, one of which is the popular Tylenol brand. Manufacturing problems have led to quality control issues in other Johnson & Johnson brands Sudafed, Benadryl, and Rolaids. In all, it is estimated the recalls have cost the company $900 million in sales. If the problems are not fixed, further recalls and significant fines from the FDA would result.
